A phase 3 trial of two tuberculosis vaccines shows limited overall protection but meaningful efficacy against extrapulmonary ...

While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, ...

The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial ...

A previous analysis examined the public health impact of new tuberculosis vaccines and predicted that a pre-exposure vaccine, targeting the acquisition of infection or primary progression would be ...

Tuberculosis, or TB, an airborne bacterial respiratory infection, is one of humanity's oldest foes and is today the world's leading cause of death from infectious disease, claiming more than 1.2 ...

Painstaking experiments have revealed the cellular signatures that signify a tuberculosis infection, providing a series of targets for new vaccines that could finally subdue one of the world’s leading ...

A vaccine protects more than 100 million infants each year from severe tuberculosis (TB), including the fatal brain swelling it can cause in babies and toddlers. But the vaccine doesn't prevent adults ...

Dr NK Arora urged people, both young and old, not to hesitate to take vaccines. He added thar vaccines are developed after ...